Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580593 · ClinicalTrials.gov registry record · Phase 1
Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00580593 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT00580593, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this trial is to determine the feasibility of conducting a randomized, double-blind, placebo-controlled trial of nocturnal noninvasive positive pressure ventilation in persons with amyotrophic lateral sclerosis with an forced vital capacity greater than or equal to 50 percent.
Interventions
- DEVICE BiPAP® S/T System
- OTHER sham-NIPPV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580593
The ClinicalTrials.gov registry entry for NCT00580593 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BiPAP® S/T System is the first listed.
NCT00580593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580593 about?
NCT00580593 is a clinical study titled "Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)". The goal of this trial is to determine the feasibility of conducting a randomized, double-blind, placebo-controlled trial of nocturnal noninvasive positive pressure ventilation in persons with amyotrophic lateral sclerosis with an forced vital capacity greater than or equal to 50 percent.
What is the current status of trial NCT00580593?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2007-04. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00580593?
The interventions under investigation include: BiPAP® S/T System (DEVICE), sham-NIPPV (OTHER).
Who is sponsoring clinical trial NCT00580593?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.